United States
Germany
Japan
United Kingdom
China
MAP2K2 Mutant (Y134H), Myc-DDK-tagged ORF clone of Homo sapiens mitogen-activated protein kinase kinase 2 (MAP2K2) as transfection-ready DNA
| Mutation | Y134H |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
Products
MAP2K2 Mutant (F57L), Myc-DDK-tagged ORF clone of Homo sapiens mitogen-activated protein kinase kinase 2 (MAP2K2) as transfection-ready DNA
| Mutation | F57L |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MAP2K2 Mutant (P128R), Myc-DDK-tagged ORF clone of Homo sapiens mitogen-activated protein kinase kinase 2 (MAP2K2) as transfection-ready DNA
| Mutation | P128R |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MAP2K2 Mutant (Y134C), Myc-DDK-tagged ORF clone of Homo sapiens mitogen-activated protein kinase kinase 2 (MAP2K2) as transfection-ready DNA
| Mutation | Y134C |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MAP2K2 Mutant (G132V), Myc-DDK-tagged ORF clone of Homo sapiens mitogen-activated protein kinase kinase 2 (MAP2K2) as transfection-ready DNA
| Mutation | G132V |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MAP2K2 Mutant (F57I), Myc-DDK-tagged ORF clone of Homo sapiens mitogen-activated protein kinase kinase 2 (MAP2K2) as transfection-ready DNA
| Mutation | F57I |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MAP2K2 Mutant (F57C), Myc-DDK-tagged ORF clone of Homo sapiens mitogen-activated protein kinase kinase 2 (MAP2K2) as transfection-ready DNA
| Mutation | F57C |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MAP2K2 Mutant (K61T), Myc-DDK-tagged ORF clone of Homo sapiens mitogen-activated protein kinase kinase 2 (MAP2K2) as transfection-ready DNA
| Mutation | K61T |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MAP2K2 Mutant (K61E), Myc-DDK-tagged ORF clone of Homo sapiens mitogen-activated protein kinase kinase 2 (MAP2K2) as transfection-ready DNA
| Mutation | K61E |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MAP2K2 Mutant (F57V), Myc-DDK-tagged ORF clone of Homo sapiens mitogen-activated protein kinase kinase 2 (MAP2K2) as transfection-ready DNA
| Mutation | F57V |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MAP2K2 Mutant (K273R), Myc-DDK-tagged ORF clone of Homo sapiens mitogen-activated protein kinase kinase 2 (MAP2K2) as transfection-ready DNA
| Mutation | K273R |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MAP2K2 Mutant (A62P), Myc-DDK-tagged ORF clone of Homo sapiens mitogen-activated protein kinase kinase 2 (MAP2K2) as transfection-ready DNA
| Mutation | A62P |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MAP2K2 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRFP-C-RS |
MAP2K2 CRISPRa kit - CRISPR gene activation of human mitogen-activated protein kinase kinase 2
| Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
MAPKK 2 (1-400, His-tag) human recombinant protein, 10 µg
| Tag | His-tag |
| Expression Host | E. coli |
活动过滤器
优化搜索结果
Expression Hosts
Lentivirus
Tags
Mutants
Brands
Families
Pathways
- Acute myeloid leukemia (14)
- B cell receptor signaling pathway (14)
- Bladder cancer (14)
- Chronic myeloid leukemia (14)
- Endometrial cancer (14)
- ErbB signaling pathway (14)
- Fc epsilon RI signaling pathway (14)
- Gap junction (14)
- Glioma (14)
- GnRH signaling pathway (14)
- Insulin signaling pathway (14)
- Long-term depression (14)
- Long-term potentiation (14)
- MAPK signaling pathway (14)
- Melanogenesis (14)
- Melanoma (14)
- Natural killer cell mediated cytotoxicity (14)
- Neurotrophin signaling pathway (14)
- Non-small cell lung cancer (14)
- Pathways in cancer (14)
- Prion diseases (14)
- Prostate cancer (14)
- Regulation of actin cytoskeleton (14)
- Renal cell carcinoma (14)
- T cell receptor signaling pathway (14)
- Thyroid cancer (14)
- Toll-like receptor signaling pathway (14)
- VEGF signaling pathway (14)
- Vascular smooth muscle contraction (14)
